Characterization of the binding of MRTX1133 as an avenue for the discovery of potential KRASG12D inhibitors for cancer therapy

Abdul Rashid Issahaku(University of the Free State), Johra Khan(Majmaah University), Sami G. Almalki(Creighton University), Clement Agoni(University of KwaZulu-Natal), Sahar M. Aldosari(Majmaah University), Namutula Mukelabai(University of KwaZulu-Natal), Mithun Rudrapal(Vignan's Foundation for Science, Technology & Research)
Scientific Reports
October 22, 2022
Cited by 94


Related Papers